Skip to main content
Top
Published in: Abdominal Radiology 1/2017

01-01-2017 | Classics in Abdominal Imaging

The “ivory vertebra” sign

Authors: Greg Matthews, Raymond B. Dyer

Published in: Abdominal Radiology | Issue 1/2017

Login to get access

Abstract

The ivory verterba sign is indicative of diffuse sclerosis of a vertebral body. Though classically associated with osteoblastic metastatic disease, the appearance has also been described with multiple other conditions. Observable on Compute tomography or standard radiography, this sign can serve as a important clue to a systemic disease process.
Literature
1.
go back to reference Souques A, Lafourcade T (1925) Vertebra d’ivoire” dans un cas de cancer metastatique de la colonne vertebrale. Rev Neurol 32:3–10 Souques A, Lafourcade T (1925) Vertebra d’ivoire” dans un cas de cancer metastatique de la colonne vertebrale. Rev Neurol 32:3–10
3.
go back to reference Frenzel L, Suarez F, Chandesris M, Hermine O (2012) Ivory vertebra and systemic mastocytosis. Jt Bone Spine 79:319–321CrossRef Frenzel L, Suarez F, Chandesris M, Hermine O (2012) Ivory vertebra and systemic mastocytosis. Jt Bone Spine 79:319–321CrossRef
Metadata
Title
The “ivory vertebra” sign
Authors
Greg Matthews
Raymond B. Dyer
Publication date
01-01-2017
Publisher
Springer US
Published in
Abdominal Radiology / Issue 1/2017
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0866-9

Other articles of this Issue 1/2017

Abdominal Radiology 1/2017 Go to the issue

Classics in Abdominal Imaging

The “starry sky” liver

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.